General enquiries

For general enquiries:

T: 020 7487 3892
E: [email protected]

Or write to us at:

The Cure Parkinson's Trust
120 New Cavendish Street
London
W1W 6XX

Latest

Further Evidence of Neuroprotection of Simvastatin in Parkinson's

Researchers in Israel have recently published an interesting new study which provides a novel insight and further independent support for simvastatin which CPT is clinically testing in people with Parkinson's.
My Prudential RideLondon Challenge

Over the weekend of the 15 -16 August, please join us for the nation-wide ‘virtual’ My Prudential RideLondon challenge and support our pioneering Parkinson's research. Get on your bike, or any form of self-propelled wheels, and ride around your local area to take part. Find out more...
‘Virtual’ Edinburgh Marathon Festival 2020 Challenge

Join this year’s ‘virtual’ Edinburgh Marathon Festival Challenge around your local area in support of The Cure Parkinson’s Trust. Participants can choose how and when to take part in this virtual running event with different distances that can be completed anytime between now and the 31 December.
'Cabbages and Kings Magazine' in support of CPT

Long term supporters from the Leicestershire, Northamptonshire and Rutland Committee led by Meriel Buxton have produced and printed a wonderful magazine 'Cabbages and Kings' to help raise funds for CPT’s research.

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.
New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut...
Science news

Read the latest Parkinson's science and research news here.
Trials - Repurposed Drugs

Our International Linked Clinical Trials initiative (iLCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Apply for Funding
The NAC Trial - the facts
Our story
Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.
Alpha-synuclein and Parkinson's

The Science of Parkinson's - Dr Simon Stott, Deputy Director Research

Science news

Read the latest Parkinson's science and research news here. Read more

The Cure Collective

The Cure Collective is an opportunity to join like-minded individuals who are committed to help drive forward the quest to find a cure for Parkinson’s... Read more